NOV 03, 2016 07:30 AM PDT
Fusion genes: what , why and how
Presented at the Clinical Diagnostics & Research Virtual Event
CONTINUING EDUCATION (CME/CE/CEU) CREDITS: P.A.C.E. CE | Florida CE
2 6 106

Speakers:
  • Global Product Manager, NGS, QIAGEN
    Biography
      Raed Samara, PhD is a Global Product Manager for NGS technologies at QIAGEN, with a focus on pre-analytics and targeted enrichment. Prior to joining QIAGEN, he was a postdoctoral fellow at the National Cancer Institute conducting research in the field of cancer immunology with emphasis on identifying strategies to boost the efficacy of cancer vaccines. He received his Ph.D. degree from Georgetown University in tumor biology.

    Abstract:
    Fusion genes are hybrid genes formed by the fusion of two separate genes. Translocation, interstitial deletion and chromosomal inversions are some of the genetic events that can lead to the formation of fusion genes.

    The occurrence of fusion genes and its implications in cancer have already been known, but the emergence of NGS technology – especially RNA sequencing – offers the potential to detect novel gene fusions.

    You can learn more about fusion genes and applying NGS to detect them at our upcoming webinar, presented by Raed Samara, Ph.D., QIAGEN’s Global Product Manager for NGS technologies.

    In this webinar, Dr. Raed Samara will cover:
    1. Fusion genes: what they are and a historical perspective
    2. Fusion gene detection: the current status
    3. RNA sequencing vs. digital RNA sequencing
    4. How to detect and accurately quantify novel fusion genes in your sample

    Show Resources
    Loading Comments...